Cargando…

Cardiovascular Manifestations of Mitochondrial Disease

Genetic mitochondrial cardiomyopathies are uncommon causes of heart failure that may not be seen by most physicians. However, the prevalence of mitochondrial DNA mutations and somatic mutations affecting mitochondrial function are more common than previously thought. In this review, the pathogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duran, Jason, Martinez, Armando, Adler, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628328/ https://www.ncbi.nlm.nih.gov/pubmed/31083569 http://dx.doi.org/10.3390/biology8020034

Ejemplares similares

Renal manifestations of genetic mitochondrial disease
por: O’Toole, John F
Publicado: (2014)

Endocrine Manifestations and New Developments in Mitochondrial Disease
por: Ng, Yi Shiau, et al.
Publicado: (2021)

Mitochondria and the eye—manifestations of mitochondrial diseases and their management
por: Chen, Benson S., et al.
Publicado: (2023)

Cardiovascular Manifestations and Management in ADPKD
por: Sagar, Priyanka S., et al.
Publicado: (2023)

Mitochondrial mechanosensor in cardiovascular diseases
por: Caffarra Malvezzi, Cristina, et al.
Publicado: (2020)

Cardiovascular Manifestations of COVID-19
por: Altamimi, Hasan, et al.
Publicado: (2020)

Cardiovascular Manifestations and Complications of Pheochromocytomas and Paragangliomas
por: Y-Hassan, Shams, et al.
Publicado: (2020)

Cardiovascular Manifestations of COVID-19 Infection
por: Magadum, Ajit, et al.
Publicado: (2020)

AMPK, Mitochondrial Function, and Cardiovascular Disease
por: Wu, Shengnan, et al.
Publicado: (2020)

COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations
por: Shu, Hongyang, et al.
Publicado: (2023)

Mitochondrial Disorders with Significant Ophthalmic Manifestations
por: Al-Enezi, Mona, et al.
Publicado: (2008)

Cardiovascular manifestation and treatment in COVID-19
por: Su, Yen-Bo, et al.
Publicado: (2020)

Cardiovascular manifestations in idiopathic inflammatory myopathies
por: Shah, Meera, et al.
Publicado: (2023)

Mitochondrial MiRNA in Cardiovascular Function and Disease
por: Song, Rui, et al.
Publicado: (2019)

Cardiovascular manifestations and treatment considerations in COVID-19
por: Kang, Yu, et al.
Publicado: (2020)

The Role of Mitochondrial DNA Mutations in Cardiovascular Diseases
por: Dabravolski, Siarhei A., et al.
Publicado: (2022)

Mitochondrial Dysfunction and Therapeutic Perspectives in Cardiovascular Diseases
por: Liu, Yu, et al.
Publicado: (2022)

Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer
por: Rocca, Carmine, et al.
Publicado: (2023)

The Increased Cardiovascular Risk in Patients Affected by Autoimmune Diseases: Review of the Various Manifestations
por: Durante, Alessandro, et al.
Publicado: (2015)

Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies
por: Bunu, Diana-Maria, et al.
Publicado: (2019)

Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes
por: Regitz-Zagrosek, Vera, et al.
Publicado: (2022)

Gastrointestinal manifestations of mitochondrial disorders: a systematic review
por: Finsterer, Josef, et al.
Publicado: (2016)

Mitochondrial Implications in Cardiovascular Aging and Diseases: The Specific Role of Mitochondrial Dynamics and Shifts
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Neuro-ophthalmic manifestations of mitochondrial disorders and their management
por: Lock, Jane H., et al.
Publicado: (2020)

The Therapeutic Strategies Targeting Mitochondrial Metabolism in Cardiovascular Disease
por: Huang, Xiaoyang, et al.
Publicado: (2022)

Multimodality Imaging in the Evaluation of Cardiovascular Manifestations of Malignancy
por: Jiménez-Juan, Laura, et al.
Publicado: (2011)

Mitochondrial DNA as an inflammatory mediator in cardiovascular diseases
por: Nakayama, Hiroyuki, et al.
Publicado: (2018)

A Systematic Review of the Cardiovascular Manifestations and Outcomes in the Setting of Coronavirus-19 Disease
por: Thakkar, Samarthkumar, et al.
Publicado: (2020)

Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations
por: Becker, Yann, et al.
Publicado: (2019)

Acute and Chronic Cardiovascular Manifestations of COVID-19: Role for Endotheliopathy
por: Cooke, John P., et al.
Publicado: (2021)

Imaging for Cardiovascular Complications of COVID-19: Cardiac Manifestations in Context
por: Crosier, Rebecca, et al.
Publicado: (2023)

Targeting Mitochondrial Dynamics Proteins for the Development of Therapies for Cardiovascular Diseases
por: Blagov, Alexander V., et al.
Publicado: (2022)

Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases
por: Sun, Mingchu, et al.
Publicado: (2023)

Cardiovascular manifestation of end-stage liver disease and perioperative echocardiography for liver transplantation: anesthesiologist’s view
por: Han, Sangbin, et al.
Publicado: (2022)

Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease
por: Li, Anqi, et al.
Publicado: (2022)

Mitochondrial Dysfunction and Cardiovascular Disease: Pathophysiology and Emerging Therapies
por: Stamerra, Cosimo Andrea, et al.
Publicado: (2022)

The Canadian Women’s Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women — Chapter 5: Sex- and Gender-Unique Manifestations of Cardiovascular Disease
por: Pacheco, Christine, et al.
Publicado: (2021)

Natural Bioactive Compounds As Protectors Of Mitochondrial Dysfunction In Cardiovascular Diseases And Aging
por: Arauna, Diego, et al.
Publicado: (2019)

Cardiovascular manifestations in Marfan syndrome
por: Lazea, Cecilia, et al.
Publicado: (2021)

Cardiovascular Manifestations of COVID-19
por: Nandy, Sneha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qcqier39dobrsmhlf74a53nf8f